Charlotte Palmer
Oxford-BMS Postdoctoral Fellow
- Postdoctoral Researcher in Myeloma Epigenetic Target Discovery
Recent publications
-
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Journal article
Kurata K. et al, (2023), Blood cancer j, 13
-
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Journal article
Kurata K. et al, (2023), Blood cancer j, 13
-
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers.
Journal article
Agarwal G. et al, (2022), Cancers (basel), 15
-
Prospective assessment of myeloma tumour burden and bone disease using DW-MRI and exploratory bone biomarkers
Journal article
Agarwal G. et al, (2022), Hemasphere, 6, 777 - 778
-
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.
Journal article
Whitburn J. et al, (2022), Sci adv, 8